BrainXell

About:

BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery.

Website: https://brainxell.com/

Twitter/X: brainxell_inc

Description:

BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons.

Total Funding Amount:

$13.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)brainxell.com

Founders:

Su-Chun Zhang

Number of Employees:

1-10

Last Funding Date:

2021-09-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai